New Findings | 8 Feb 2013 Resisting Arrest Regulatory T cells outmatched in active disease Carol Cruzan Morton If immunology had its own comic book series, a recurring MS story line would pit... Laboratory Research CommentRecommendBookmark
New Findings | 25 Jan 2013 Spinal Vision Advanced MRI measures discern disability levels better than standard techniques Carol Cruzan Morton Brain scans routinely help doctors diagnose MS, but the discrepancy between the amount of visibly damaged tissue and... Laboratory Research, Methods CommentRecommendBookmark
New Findings | 9 Jan 2013 Bad Presentation Researchers identify cells that might incite nerve-damaging T cells in MS Mitch Leslie T cells don’t go rogue without provocation. Researchers have now fingered the cells that might... Laboratory Research CommentRecommendBookmark
New Findings | 10 Dec 2012 Pregnancy’s Secret Weapon? Estrogen-derived molecule could dampen MS Rachel Tompa Unlike weight gain and swollen feet, one side effect of pregnancy comes as a welcome relief for... Laboratory Research CommentRecommendBookmark
New Findings | 6 Dec 2012 Conducting Neural Dissonance Ion channel promotes neurodegeneration in mice Carol Cruzan Morton Inappropriate immune activity has occupied center stage in the study of MS, but clinical symptoms... Laboratory Research CommentRecommendBookmark
New Findings | 16 Nov 2012 Enzyme, Exposed MALT1 emerges as a potentially druggable target for MS Stephani Sutherland In experimental autoimmune encephalomyelitis, and perhaps in multiple sclerosis, too, T helper 17 cells... Laboratory Research CommentRecommendBookmark
New Findings | 26 Oct 2012 Benign MS Expresses Itself Patients who’ve received controversial diagnosis show unique gene-activity profile Mitch Leslie Benign multiple sclerosis may sound like a contradiction in terms, but some patients... Laboratory Research CommentRecommendBookmark
New Findings | 3 Oct 2012 Foreseeing the Future? Molecular signature might predict likelihood of relapse Carol Cruzan Morton Two women age 30 with a loss of vision in one eye can each learn that they have MS in... Clinical Research, Laboratory Research CommentRecommendBookmark
New Findings | 21 Sep 2012 Dimethyl Fumarate Shows Efficacy in Phase III Clinical Studies Experimental oral drug tolerated relatively well Carol Cruzan Morton The first peer-reviewed phase III clinical trials of an experimental oral drug for the most common form... Clinical Research, Drug Development CommentRecommendBookmark
New Findings | 17 Sep 2012 Why TH17 Cells Turn to the Dark Side Study identifies protein that spurs potential MS culprit to become pathogenic Mitch Leslie Whenever a criminal gets arrested, everyone asks why he went bad. Was it his upbringing? Did he... Laboratory Research CommentRecommendBookmark